Korean Air Renews IATA 'Pharmaceutical Air Transport Quality Certification'

Korean Air announced on October 30 that it has renewed its 'CEIV Pharma (Center of Excellence for Independent Validators Pharma)' certification from the International Air Transport Association (IATA) for pharmaceutical air transport quality.

This is an international standard certification that demonstrates expertise in the air transport of pharmaceuticals, which is considered a specialized type of cargo. Global logistics experts rigorously evaluate over 280 items, including pharmaceutical transport procedures, storage facilities, equipment, and regulations, before issuing the certification. Korean Air first obtained the certification in June 2019 and safely transported pharmaceuticals, including vaccines, both domestically and internationally during the COVID-19 pandemic.

The pharmaceutical air transport quality certification requires a re-certification audit every three years to maintain qualification. This year marks the second time Korean Air has renewed its certification, following the previous renewal in 2022.

For this year’s re-certification, Korean Air formed a company-wide task force, conducted a comprehensive review of the entire pharmaceutical transport process, revised and supplemented transport manuals, improved procedures, and strengthened internal inspections.

This content was produced with the assistance of AI translation services.